Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.

Autor: Alvarez‐Fernández, Carmen1,2,3 (AUTHOR) calvarezf@santpau.cat, Escribà‐Garcia, Laura1,2,3 (AUTHOR), Caballero, AC1,2,3,4 (AUTHOR), Escudero‐López, Eva1,2,3,4 (AUTHOR), Ujaldón‐Miró, Cristina1,2,3,4 (AUTHOR), Montserrat‐Torres, Rosanna1,2,3 (AUTHOR), Pujol‐Fernández, Paula1,2,3 (AUTHOR), Sierra, Jorge1,3,4 (AUTHOR), Briones, Javier1,2,3,4 (AUTHOR) jbriones@santpau.cat
Zdroj: Clinical & Translational Immunology. 2021, Vol. 10 Issue 4, p1-15. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje